Stay updated on RC48-ADC in HER2+ Urothelial Cancer Clinical Trial
Sign up to get notified when there's something new on the RC48-ADC in HER2+ Urothelial Cancer Clinical Trial page.

Latest updates to the RC48-ADC in HER2+ Urothelial Cancer Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedRevision labels updated from v3.4.1 to v3.4.2, indicating a minor backend/content refresh. No study information or user-facing data are affected.SummaryDifference0.1%

- Check20 days agoChange DetectedRevision update from v3.4.0 to v3.4.1 was applied, with UI and layout tweaks across the page.SummaryDifference0.1%

- Check27 days agoChange DetectedThe page now includes a glossary toggle; metadata labels were updated to include 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data', and 'Revision: v3.4.0', while older labels 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4' were removed.SummaryDifference0.2%

- Check42 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4 with no substantive changes to the study details or page content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check63 days agoChange DetectedLocations section now lists new sites (Anhui, Beijing Municipality, Guangdong, Hunan, Shandong, Sichuan) and removes the old location blocks, reflecting updated site availability.SummaryDifference0.8%

- Check92 days agoChange DetectedThe updates consist of a wording change to the Publications note and a revision version marker. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to RC48-ADC in HER2+ Urothelial Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the RC48-ADC in HER2+ Urothelial Cancer Clinical Trial page.